OrganiGram Closes Building Acquisition and Begins Project to Dramatically Expand Capacity

Visit the OrganiGram Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

Organigram large logo
Organigram Completes Purchase and Expansion Design of Property

MONCTON, NEW BRUNSWICK–(Marketwired – Oct. 11, 2016) OrganiGram Holdings Inc. (TSXV: OGI) (OTC: OGRMF) (the “Company” or “OrganiGram”) is pleased to announce the closing of its previously announced acquisition of the industrial property adjacent to the Company’s existing facility in Moncton, N.B.

The acquisition, which includes a 136,000 square foot building situated on 10 acres of industrial land, facilitates the Company’s phased expansion initiatives related to cannabis production and extracts processing. The Board of Directors has approved the initial buildout of approximately 70,000 square feet. This phase of construction will bring Organigram’s annual production capacity to approximately 16,000 kg of flower, and approximately 6,400 kg of fan and sweet leaf. The planned expansion also includes a state of the art 20,000 square foot commercial scale oils and extracts manufacturing facility that is engineered and designed in collaboration with our partners in Colorado, TGS International LLC. This phase of our fully funded expansion will commence immediately and is expected to be completed and operational by the fall of 2017.

The remaining square footage of the acquired building is being subleased by OrganiGram and provides the Company with approximately $777,000 in lease payments and shared operating costs on an annual basis. This allows the Company to keep its overhead low and to pursue the expansion initiatives in a more cost effective manner.

We are fortunate to be able to consolidate the acquired property with our existing location and transition to the next phase of our expanded production platform immediately. We believe that we have positioned OrganiGram to undertake incremental production and processing capabilities in a timelier manner than most of its competitors.

denis arsenaultDenis Arsenault, Chief Executive Officer of OrganiGram

Having a blue chip tenant occupy the space which we don’t currently require, allows us to execute this expansion more cost effectively and gives us the ability to utilize our newly acquired space in ways that create value for OrganiGram shareholders.

For more information, visit

About OrganiGram Holdings Inc.

OrganiGram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, OrganiGram Inc., is a licensed producer of medical marijuana in Canada. OrganiGram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. OrganiGram’s facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations (“ACMPR”).

Original press release:

For fact-based information on Organigram, view the company’s sponsored Investor Dashboard.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter